NCT02442011

Brief Summary

This is a biorepository of blood specimens from subjects with different Hematological disorders.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
45mo left

Started Jan 2014

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress77%
Jan 2014Jan 2030

Study Start

First participant enrolled

January 1, 2014

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

May 7, 2015

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 13, 2015

Completed
14.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2030

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2030

Last Updated

January 6, 2026

Status Verified

January 1, 2026

Enrollment Period

16 years

First QC Date

May 7, 2015

Last Update Submit

January 2, 2026

Conditions

Hematological Disorders

Keywords

Hematology Biobank

Outcome Measures

Primary Outcomes (1)

  • Biobank

    To have specimens available for IRB approved studies

    5 years

Eligibility Criteria

Age12 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

\- Adult and pediatric patients 12 years of age and older

You may qualify if:

  • Above 12 years of age and referred to the Hematology Division at Montefiore-Einstein
  • Under the care of a Montefiore-Einstein hematologist for a hematologic disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Montefiore Medical Center

The Bronx, New York, 10467, United States

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

Whole blood samples will be processed fresh or frozen and stored in cryo vials at -80°C for future isolation of DNA. DNA isolation will be done using commercially available kits such as Applied Biosystems' "DNA Isolation from Fresh and Frozen Blood, Tissue Culture" http://tools.lifetechnologies.com/content/sfs/manuals/cms\_041387.pdf Plasma needed for biomarkers analysis we be obtained from whole blood samples. Whole blood will be spun down, plasma and sediment will be separated and stored in cryo vials at -80°C. Red cells and platelets will be stored at 4C. Red cell hemolysate may be stored at 4C or stored in cryo vials.

MeSH Terms

Conditions

Hematologic Diseases

Condition Hierarchy (Ancestors)

Hemic and Lymphatic Diseases

Study Officials

  • Henny Billett

    Albert Einstein College of Medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Swati Goel

CONTACT

7189204137swgoel@montefiore.org

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 7, 2015

First Posted

May 13, 2015

Study Start

January 1, 2014

Primary Completion (Estimated)

January 1, 2030

Study Completion (Estimated)

January 1, 2030

Last Updated

January 6, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations

US(1)